1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ANAPTYSBIO INC
AnaptysBio Inc XNAS: ANAB

AnaptysBio Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, inclu...

Read More
21.09 -1.44 (-6.39%)
48.18% Fall from 52W High
537.2K
XNAS Volume

XNAS 04 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The latest board meeting for AnaptysBio Inc took place on 04 Sep 2025, for the purpose of 2025 Wells Fargo Healthcare Conference See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
11.0 / 100
Momentum Score
Technically Neutral
54.6 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
46
1Yr Price target upside is 116%
10 analysts

9

S

13

W

0

O

3

T

SWOT Analysis

AnaptysBio Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..